查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1706117

2025年門脈高壓管理全球市場報告

Portal Hypertension Management Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年門靜脈高壓管理市場規模將強勁成長。到 2029 年，這一數字將成長至 42.3 億美元，年複合成長率（CAGR）為 6.6%。預測期內的成長可歸因於醫療保健基礎設施投資的增加、醫療保險覆蓋範圍的擴大、有利的法規環境和加快的核准流程、專注於了解門靜脈高壓病理生理的持續研究和開發活動，以及透過遠端監控技術促進持續的患者管理。預測期內的關鍵趨勢包括遠端醫療的日益普及、生物工程肝組織等醫療技術的持續進步、個人化醫療的日益成長趨勢、針對個別患者特徵的標靶治療的開發以及包括彈性成像等非侵入性成像技術在內的診斷方法的改進。

由於肝炎等肝病的盛行率不斷上升，門靜脈高壓管理市場預計將會成長。肝病包括多種影響肝臟結構和功能的疾病，常導致黃疸、疲勞和腹痛等症狀。原因包括病毒感染、酗酒和代謝紊亂。肝病門靜脈高壓的治療旨在降低門靜脈系統的壓力，從而減輕靜脈曲張出血、腹水和肝性腦病變等併發症，並改善患者的預後。例如，澳洲癌症協會報告稱，2022 年澳洲診斷出約 2,905 例新的肝癌病例，突顯出發病率上升推動了市場成長。

門脈高壓管理的主要企業正在開發微創設備，以改善治療結果並最大限度地降低手術風險。這些儀器旨在以對組織的破壞最小的方式執行手術，通常透過小切口或自然的身體孔口進行。例如，美敦力公司於 2023 年 11 月獲得 FDA核准其 Symplicity Spyral 腎臟去神經支配系統，該系統使用射頻能源針對腎臟附近的神經來控制高血壓。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球門脈高壓症管理 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球門脈高壓管理市場：成長率分析
  • 全球門脈高壓管理市場表現：規模與成長，2019-2024
  • 全球門脈高壓管理市場預測：規模與成長，2024-2029 年，2034 年
  • 全球門脈高壓管理總目標市場（TAM）

第6章市場區隔

  • 全球門靜脈高壓管理市場（依治療類型、表現和預測）：2019-2024 年、2024-2029 年、2034 年
  • 製藥
  • 非手術治療
  • 外科手術
  • 全球門脈高壓管理市場（依手術類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 經頸靜脈肝內門體分流術（TIPS）
  • 其他手術類型
  • 全球門脈高壓管理市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 專科診所
  • 其他最終用戶
  • 全球門脈高壓症管理市場，依藥物類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • BETA受體阻斷劑
  • 血管擴張劑
  • 利尿劑
  • 抗生素
  • 其他藥物
  • 全球門脈高壓管理市場，依非手術程序類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 內視鏡靜脈曲張結紮術（EVL）
  • 內視鏡硬化療法
  • 經頸靜脈肝內門體分流術（TIPS）
  • 球囊阻塞
  • 全球門靜脈高壓管理市場，依手術類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 肝臟移植
  • 門體分流術
  • 門靜脈減壓手術
  • 其他外科手術

第7章 區域和國家分析

  • 全球門脈高壓管理市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球門靜脈高壓管理市場：依國家、地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 門脈高壓管理市場：競爭格局
  • 門脈高壓管理市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • AstraZeneca PLC
  • Novartis AG
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Amgen Inc.
  • Gilead Sciences Inc.
  • Merck & Co.
  • Boehringer Ingelheim International GmbH
  • Amneal Pharmaceuticals LLC.
  • Lupin Ltd.
  • Daiichi Sankyo
  • Dr. Falk Pharma GmbH
  • Cumberland Pharmaceuticals Inc.
  • Ono Pharmaceutical Co. Ltd.
  • Chiasma Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年門脈高壓管理市場：提供新機會的國家
  • 2029 年門脈高壓管理市場：細分領域帶來新機會
  • 2029 年門脈高壓管理市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r30989

Portal hypertension management encompasses strategies aimed at treating and preventing complications arising from elevated pressure in the portal vein system, often associated with liver cirrhosis. These measures include lifestyle adjustments, medication administration (such as beta-blockers), and procedures such as variceal banding to prevent or treat complications such as variceal bleeding and ascites.

The primary approaches to portal hypertension management include medication, non-surgical procedures, and surgery. Medication for portal hypertension typically includes nonselective beta-blockers, vasoconstrictors, diuretics, and antibiotics, which are used to manage conditions such as variceal bleeding, ascites, and bacterial infections in patients with increased portal pressure. Non-surgical procedures involve techniques such as transjugular intrahepatic portosystemic shunt (TIPS), which is employed across various healthcare settings including hospitals, specialty clinics, and others.

The portal hypertension management research report is one of a series of new reports from The Business Research Company that provides portal hypertension management market statistics, including the portal hypertension management industry's global market size, regional shares, competitors with a portal hypertension management market share, detailed portal hypertension management market segments, market trends and opportunities, and any further data you may need to thrive in the portal hypertension management industry. This portal hypertension management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The portal hypertension management market size has grown strongly in recent years. It will grow from $3.07 billion in 2024 to $3.28 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to the increased prevalence of liver diseases, growth in the geriatric population, awareness and screening programs, economic burden of liver diseases, approval done for new drugs and therapies, and improvement done for diagnostic methods.

The portal hypertension management market size is expected to see strong growth in the next few years. It will grow to $4.23 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising investment in healthcare infrastructure, broader health insurance coverage, favorable regulatory environments and expedited approval processes, ongoing r&d activities focused on understanding the pathophysiology of portal hypertension, and remote monitoring technologies will facilitate continuous patient management. Major trends in the forecast period include growing adoption of telemedicine, continued advancements in medical technology, such as bio-engineered liver tissue, growth in personalized medicine, development of targeted therapies tailored to individual patient profiles, improved diagnostic methods, including non-invasive imaging technologies like elastography.

The portal hypertension management market is poised for growth due to an increasing prevalence of liver diseases such as hepatitis. Liver diseases encompass a spectrum of conditions affecting liver structure and function, often resulting in symptoms such as jaundice, fatigue, and abdominal pain. Causes include viral infections, alcohol abuse, and metabolic disorders. Management of portal hypertension in liver disease aims to alleviate complications such as variceal bleeding, ascites, and hepatic encephalopathy by reducing pressure in the portal vein system, thereby improving patient outcomes. For example, in 2022, Cancer Australia reported approximately 2,905 new cases of liver cancer diagnosed in Australia, underscoring the rising incidence contributing to market growth.

Leading companies in the portal hypertension management sector are advancing minimally invasive devices to enhance treatment efficacy and minimize procedural risks. These devices are designed to perform procedures with minimal disruption to tissues, typically through small incisions or natural body openings. For instance, Medtronic Plc received FDA approval in November 2023 for the Symplicity Spyral renal denervation system, utilizing radiofrequency energy to manage hypertension by targeting nerves near the kidneys.

In February 2023, AstraZeneca Plc acquired CinCor Pharma Inc. for $1.8 billion. This acquisition enriches AstraZeneca's portfolio with CinCor's barostat (CIN-107), an aldosterone synthase inhibitor designed to lower blood pressure in treatment-resistant hypertension. CinCor Pharma Inc., based in the US, specializes in developing innovative medications for hypertension management.

Major companies operating in the portal hypertension management market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Merck & Co., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals LLC., Lupin Ltd., Daiichi Sankyo, Dr. Falk Pharma GmbH, Cumberland Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Chiasma Inc., Debiovision Inc.

North America was the largest region in the portal hypertension management market in 2024. The regions covered in the portal hypertension management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the portal hypertension management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The portal hypertension management market consists of revenues earned by entities by provide services such as medical management, endoscopic therapy, interventional radiology procedures, and monitoring and supportive care. The market value includes the value of related goods sold by the service provider or included within the service offering. The portal hypertension management market also includes sales of nonselective beta-blockers, and vasoconstrictors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Portal Hypertension Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on portal hypertension management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for portal hypertension management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The portal hypertension management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Treatment Type: Medications; Non-Surgical Procedures; Surgery
  • 2) By Procedure Type: Transjugular Intrahepatic Portosystemic Shunt (TIPS); Other Procedure Types
  • 3) By End-User: Hospitals; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Medications: Beta-Blockers; Vasodilators; Diuretics; Antibiotics; Other Medications
  • 2) By Non-Surgical Procedures: Endoscopic Variceal Ligation (EVL); Endoscopic Sclerotherapy; Transjugular Intrahepatic Portosystemic Shunt (TIPS); Balloon Occlusion
  • 3) By Surgery: Liver Transplantation; Portosystemic Shunt Surgery; Surgical Decompression Of Portal Vein; Other Surgical Procedures
  • Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi SA; Bristol-Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Portal Hypertension Management Market Characteristics

3. Portal Hypertension Management Market Trends And Strategies

4. Portal Hypertension Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Portal Hypertension Management Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Portal Hypertension Management PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Portal Hypertension Management Market Growth Rate Analysis
  • 5.4. Global Portal Hypertension Management Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Portal Hypertension Management Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Portal Hypertension Management Total Addressable Market (TAM)

6. Portal Hypertension Management Market Segmentation

  • 6.1. Global Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medications
  • Non-Surgical Procedures
  • Surgery
  • 6.2. Global Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transjugular Intrahepatic Portosystemic Shunt (TIPS)
  • Other Procedure Types
  • 6.3. Global Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End-Users
  • 6.4. Global Portal Hypertension Management Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Beta-Blockers
  • Vasodilators
  • Diuretics
  • Antibiotics
  • Other Medications
  • 6.5. Global Portal Hypertension Management Market, Sub-Segmentation Of Non-Surgical Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endoscopic Variceal Ligation (EVL)
  • Endoscopic Sclerotherapy
  • Transjugular Intrahepatic Portosystemic Shunt (TIPS)
  • Balloon Occlusion
  • 6.6. Global Portal Hypertension Management Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Transplantation
  • Portosystemic Shunt Surgery
  • Surgical Decompression Of Portal Vein
  • Other Surgical Procedures

7. Portal Hypertension Management Market Regional And Country Analysis

  • 7.1. Global Portal Hypertension Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Portal Hypertension Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Portal Hypertension Management Market

  • 8.1. Asia-Pacific Portal Hypertension Management Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Portal Hypertension Management Market

  • 9.1. China Portal Hypertension Management Market Overview
  • 9.2. China Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Portal Hypertension Management Market

  • 10.1. India Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Portal Hypertension Management Market

  • 11.1. Japan Portal Hypertension Management Market Overview
  • 11.2. Japan Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Portal Hypertension Management Market

  • 12.1. Australia Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Portal Hypertension Management Market

  • 13.1. Indonesia Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Portal Hypertension Management Market

  • 14.1. South Korea Portal Hypertension Management Market Overview
  • 14.2. South Korea Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Portal Hypertension Management Market

  • 15.1. Western Europe Portal Hypertension Management Market Overview
  • 15.2. Western Europe Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Portal Hypertension Management Market

  • 16.1. UK Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Portal Hypertension Management Market

  • 17.1. Germany Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Portal Hypertension Management Market

  • 18.1. France Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Portal Hypertension Management Market

  • 19.1. Italy Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Portal Hypertension Management Market

  • 20.1. Spain Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Portal Hypertension Management Market

  • 21.1. Eastern Europe Portal Hypertension Management Market Overview
  • 21.2. Eastern Europe Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Portal Hypertension Management Market

  • 22.1. Russia Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Portal Hypertension Management Market

  • 23.1. North America Portal Hypertension Management Market Overview
  • 23.2. North America Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Portal Hypertension Management Market

  • 24.1. USA Portal Hypertension Management Market Overview
  • 24.2. USA Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Portal Hypertension Management Market

  • 25.1. Canada Portal Hypertension Management Market Overview
  • 25.2. Canada Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Portal Hypertension Management Market

  • 26.1. South America Portal Hypertension Management Market Overview
  • 26.2. South America Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Portal Hypertension Management Market

  • 27.1. Brazil Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Portal Hypertension Management Market

  • 28.1. Middle East Portal Hypertension Management Market Overview
  • 28.2. Middle East Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Portal Hypertension Management Market

  • 29.1. Africa Portal Hypertension Management Market Overview
  • 29.2. Africa Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Portal Hypertension Management Market Competitive Landscape And Company Profiles

  • 30.1. Portal Hypertension Management Market Competitive Landscape
  • 30.2. Portal Hypertension Management Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Portal Hypertension Management Market Other Major And Innovative Companies

  • 31.1. AstraZeneca PLC
  • 31.2. Novartis AG
  • 31.3. GlaxoSmithKline plc
  • 31.4. Eli Lilly and Company
  • 31.5. Amgen Inc.
  • 31.6. Gilead Sciences Inc.
  • 31.7. Merck & Co.
  • 31.8. Boehringer Ingelheim International GmbH
  • 31.9. Amneal Pharmaceuticals LLC.
  • 31.10. Lupin Ltd.
  • 31.11. Daiichi Sankyo
  • 31.12. Dr. Falk Pharma GmbH
  • 31.13. Cumberland Pharmaceuticals Inc.
  • 31.14. Ono Pharmaceutical Co. Ltd.
  • 31.15. Chiasma Inc.

32. Global Portal Hypertension Management Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Portal Hypertension Management Market

34. Recent Developments In The Portal Hypertension Management Market

35. Portal Hypertension Management Market High Potential Countries, Segments and Strategies

  • 35.1 Portal Hypertension Management Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Portal Hypertension Management Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Portal Hypertension Management Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer